BioNTech CEO Confident Covid 19 Vaccine Will Work Against Virus Variant
Date: 2020-12-22 16:31:57
German pharmaceutical company BioNTech is confident that its coronavirus vaccine works against the new UK variant, but further studies are need to be completely sure, its chief executive Ugur Sahin said Tuesday.
The variant detected mainly in London and the southeast of England in recent weeks has sparked concern worldwide because of signs that it may spread more easily.
While there is no indication it causes more serious illness, numerous countries in Europe and beyond have restricted travel from the UK as a result.
“We don’t know at the moment if our vaccine is also able to provide protection against this new variant,” Sahin said. “But scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variants.”
Sahin said that the proteins on the UK variant are 99% the same as on the prevailing strains, and therefore BioNTech has “scientific confidence” that its vaccine will be effective.
Should the vaccine need to be adjusted for the new variant the company could do so in about 6 weeks, said Ugur, though regulators might have to approve the changes before the shots can be used.
BioNTech’s vaccine, developed together with U.S. pharmaceutical company Pfizer, is authorized for use in more than 45 countries including Britain, the United States and the EU.
Subscribe to our YouTube channel: https://bit.ly/2TwO8Gm
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit http://www.bloomberg.com/qt/live, or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake: https://cor.us/surveys/27AF30
Connect with us on…
Breaking News on YouTube: https://www.youtube.com/c/BloombergQuickTakeNews